APP and cancer: Among cancers with low MHC class I antigen processing pathway (MHC-I APP), histone modifications were seen in MHC-I APP gene promotors, leading to transcriptional silencing and decreased expression of MHC class I, causing loss of antigen presentation and immune evasion[40].